ABL1 and acute lymphoblastic leukemia: Overall, our findings may provide a rationale for novel therapy approaches, because the combined inhibition of Pin 1 and BCR‐ABL could suppress aggressive phenotypes, representing a useful tool to interfere with the mechanisms governing ph+ ALL cell progression.